MentionFox
Home › Stakes › Phibro Animal Health Corp
5%+ stakes · Schedule 13D and 13G

Phibro Animal Health Corp: 5%+ holders

Who has reported owning 5% or more of Phibro Animal Health Corp, from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more4
Filings10
Latest filing2026-08-06

Phibro Animal Health Corp has 10 Schedule 13D or 13G filings on record since 2025-12-15. 4 holders' latest filing reports 5% or more of class a common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
BFI Co., LLC48.2%19,552,186SCHEDULE 13D/A, 2026-05-222026-05-20
Fmr LLC15%3,160,281SCHEDULE 13G/A, 2026-08-062026-06-30
Millennium Management LLC5.1%1,064,608SCHEDULE 13G, 2026-07-302026-07-23
Vanguard Capital Management5.06%1,043,822SCHEDULE 13G, 2026-04-302026-03-31
Barclays PLC1.27%263,695SCHEDULE 13G/A, 2026-05-142026-03-31
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-272026-03-13

Purpose of Transaction (Item 4)

BFI Co., LLC

Item 4 of the Schedule 13D is hereby supplemented as follows: On May 20 2026, BFI entered into a Rule 10b5-1 sales plan (the "Sales Plan") with Goldman, Sachs & Co. LLC ("Broker") pursuant to which Broker is authorized and directed to sell on behalf of BFI up to 750,000 shares of Class A Common Stock through March 17, 2027, subject to satisfaction of certain conditions, including among others, minimum sale prices and limits on the number of shares that can be sold on a single trading day. All transactions under the Sales Plan are to be made in accordance with the terms and conditions of the Sales Plan. The Sales Plan was adopted to enable BFI to sell a modest portion of its shares of Class A Common Stock (and Class B Common Stock that BFI converts to Class A Common Stock). By using a Rule 10b5-1 Sales Plan, BFI can diversify its investment portfolio over an extended period of time. The Sales Plan became effective as of May 20, 2026 and shall terminate on the earliest of (a) March 17, 2027, (b) the date on which all transactions under the Sales Plan are completed, (c) the date Broker reasonably determines that: (i) the Sales Plan does not comply with Rule 10b5-1(c) or other applicable laws, (ii) BFI has not complied with the Sales Plan, or (iii) BFI's representations or warranties in the Sales Plan are not true and correct, or BFI can no longer make such representations and warranties, (d) the date Broker receives notice of the death, dissolution, liquidation, bankruptcy or …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-05-22; the filing has the rest

Timeline

FiledHolderPercentFiling
2025-12-15BFI Co., LLC49.3%SCHEDULE 13D/A
2026-02-11Barclays PLC5.1%SCHEDULE 13G
2026-03-27The Vanguard Group0%SCHEDULE 13G/A
2026-04-07Fmr LLC10.5%SCHEDULE 13G
2026-04-23BFI Co., LLC48.3%SCHEDULE 13D/A
2026-04-30Vanguard Capital Management5.06%SCHEDULE 13G
2026-05-14Barclays PLC1.27%SCHEDULE 13G/A
2026-05-22BFI Co., LLC48.2%SCHEDULE 13D/A
2026-07-30Millennium Management LLC5.1%SCHEDULE 13G
2026-08-06Fmr LLC15%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Phibro Animal Health Corp. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/phibro-animal-health
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Phibro Animal Health Corp 5%+ holders: 4 at 5% or more, largest BFI Co., LLC 48.2%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/phibro-animal-health